Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Meshalkin Research Institute of Pathology of Circulation
Age
18–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Symptomatic drug-refractory AF (with history of failure of ≥ 2 class I or III antiarrhythmic drugs) in patients referred for catheter ablation of AF
PAF with ≥1 monthly episodes or PersAF in patients who had already undergone ≥3 electrical cardioversions. PAF was defined as episodes lasting less than 7 days with spontaneous termination. PersAF was defined as lasting more than 7 days before being terminated pharmacologically or by electrical cardioversion.
History of significant hypertension (defined as SBP ≥ 160 mmHg and/or DBP ≥ 100 mmHg), receiving treatment with at least one antihypertensive medication
A glomerular filtration rate ≥45 mL/min/1⋅73 m2, with modification of diet using a renal disease formula
You may not be if
Previous atrial fibrillation ablation
Type 1 of diabetes mellitus
Structural heart disease
Secondary cause of atrial hypertension
Severe renal artery stenosis or renal arteries abnormalities
Previous operations on renal arteries
Pregnancy
Previous heart, kidney, liver, or lung transplantation
Unwillingness of participant
Clareo Health | Ganglionated Plexi Ablation vs Renal Denervation in Patients Undergoing Pulmonary Vein Isolation
